Details of the Drug Formulaction

General Information of Drug Formulation (ID: F11221)

• Formulation Name: Lamotrigine 250 mg tablet
• Company: GlaxoSmithKline

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lamotrigine	(DM8SXYG)	Bipolar disorder	6A60	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Caprylic acid	(E00017)	379	Emulsifying agent; Flavoring agent; Surfactant
FD&C blue no. 2	(E00446)	2723854	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Glyceryl monostearate	(E00310)	24699	Emollient; Emulsifying agent; Emulsion stabilizing agent; Solubilizing agent; Surfactant; Viscosity-controlling agent
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triethyl citrate	(E00128)	6506	Plasticizing agent; Solvent